Tuesday, March 17

Healthcare

Merck, Daiichi post mid-stage data for novel lung cancer drug

09/08/20241 Min Read

cancer Daiichi data drug lung Merck midstage post

Previous ArticleCigna to offer biosimilar to J&J’s arthritis drug Stelara at $0 out-of-pocket

Next Article Piper Sandler ups Intra-Cellular to chubby, cites Caplyta potential